Loading organizations...
Loading organizations...
Single-cell analysis for research, diagnostics, and therapeutics.
ThinkCyte has raised $63.3M across 3 funding rounds.
ThinkCyte has raised $63.3M in total across 3 funding rounds.
ThinkCyte has raised $63.3M in total across 3 funding rounds.
ThinkCyte's investors include SPARX Group.
ThinkCyte has raised $63.3M across 3 funding rounds. Most recently, it raised $15.0M Series C Extension in August 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Aug 30, 2024 | $15.0M Series C Extension | ||
| Nov 28, 2023 | $22.3M Other Equity | ||
| May 19, 2021 | $26.0M Series B | SPARX Group |